COVID-19 and mortality in rare rheumatic diseases, a warning bell? (2021)
Attributed to:
MICA: Treatment According to Response in Giant cEll arTeritis (TARGET)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keaa889
PubMed Identifier: 33410464
Publication URI: http://europepmc.org/abstract/MED/33410464
Type: Journal Article/Review
Volume: 60
Parent Publication: Rheumatology (Oxford, England)
Issue: 4
ISSN: 1462-0324